does medicaid cover glp-1 injections US states drop coverage of weight-loss drugs as demand rises | US healthcare Connecticut is moving to eliminate

Clinical considerations for GLP-1 patients Ensure weight has been stable for at least 3 months before commencing fat dissolving treatment active weight loss changes the target anatomy between sessions GLP-1 patients may present with reduced skin elasticity in previously larger areas skin quality assessment is particularly important before treating the abdomen or arms Fat volumes in post-GLP-1 patients can be moderate to significant Aqualyx is generally better suited for larger deposits

This suggests that further research, especially well-designed, long-term clinical trials, may be warranted

If a product claims GLP-1 effects but contains no GLP-1 compounds and uses a delivery method with no proven efficacy, the claims do not match the science

How Mounjaro & Other Weight Loss Injections May Impact Your Periods Weight Loss and Hormonal Changes Your fat tissue produces oestrogen

S2CID 2563606

But in Canada they are restricted: Ads that feature the name of a prescription drug cannot say what it does, and vice versa